Remedee Labs

Curated by Signal

Developer of endorphin stimulation therapy for pain management

Overview

Developer of endorphin stimulation therapy for pain management The platform has developed endorphin stimulation therapy using patented Microelectronic Endorphin Trigger (MEET) technology. Multiple clinical trials are ongoing for therapies such as innocuity, arthrosis, surgical pain, and migraine among others.

Key facts

Founded: 2016
Headquarters: Meylan, France
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

MyRobotics
Developer of an electrically stimulating device to measure taste sensitivity
Life Sciences TechnologyParis, France
Gynov
Developer of pharmaceuticals and dietary supplements for women health
Life Sciences TechnologyBordeaux, France
Panaxium
Developer of medical equipment for surgeons and neurologists to treat brain injuries
Life Sciences TechnologyAix-en-Provence, France

About Remedee Labs

What does Remedee Labs do?

Developer of endorphin stimulation therapy for pain management The platform has developed endorphin stimulation therapy using patented Microelectronic Endorphin Trigger (MEET) technology.

Where is Remedee Labs headquartered?

Remedee Labs is headquartered in Meylan, France.

When was Remedee Labs founded?

Remedee Labs was founded in 2016.

Which sector is Remedee Labs in?

Remedee Labs operates in Life Sciences Technology.

Who are Remedee Labs's competitors?

Companies similar to Remedee Labs include MyRobotics, Gynov, and Panaxium.